Guirado Ramon, Perez-Rando Marta, Sanchez-Matarredona David, Castrén Eero, Nacher Juan
Neurobiology Unit and Program in Basic and Applied Neurosciences, Cell Biology Department,Universitat de València,Spain.
Neuroscience Centre, University of Helsinki,Finland.
Int J Neuropsychopharmacol. 2014 Oct;17(10):1635-46. doi: 10.1017/S1461145714000406. Epub 2014 Apr 30.
Novel hypotheses suggest that antidepressants, such as the selective serotonin reuptake inhibitor fluoxetine, induce neuronal structural plasticity, resembling that of the juvenile brain, although the underlying mechanisms of this reopening of the critical periods still remain unclear. However, recent studies suggest that inhibitory networks play an important role in this structural plasticity induced by fluoxetine. For this reason we have analysed the effects of a chronic fluoxetine treatment in the hippocampus and medial prefrontal cortex (mPFC) of transgenic mice displaying eGFP labelled interneurons. We have found an increase in the expression of molecules related to critical period plasticity, such as the polysialylated form of the neural cell adhesion molecule (PSA-NCAM), GAD67/65 and synaptophysin, as well as a reduction in the number of parvalbumin expressing interneurons surrounded by perineuronal nets. We have also described a trend towards decrease in the perisomatic inhibitory puncta on pyramidal neurons in the mPFC and an increase in the density of inhibitory puncta on eGFP interneurons. Finally, we have found that chronic fluoxetine treatment affects the structure of interneurons in the mPFC, increasing their dendritic spine density. The present study provides evidence indicating that fluoxetine promotes structural changes in the inhibitory neurons of the adult cerebral cortex, probably through alterations in plasticity-related molecules of neurons or the extracellular matrix surrounding them, which are present in interneurons and are known to be crucial for the development of the critical periods of plasticity in the juvenile brain.
新的假说表明,抗抑郁药,如选择性5-羟色胺再摄取抑制剂氟西汀,可诱导神经元结构可塑性,类似于幼年期大脑,尽管关键期重新开启的潜在机制仍不清楚。然而,最近的研究表明,抑制性网络在氟西汀诱导的这种结构可塑性中起重要作用。因此,我们分析了慢性氟西汀治疗对转基因小鼠海马体和内侧前额叶皮质(mPFC)的影响,这些小鼠的中间神经元用绿色荧光蛋白(eGFP)标记。我们发现,与关键期可塑性相关的分子表达增加,如神经细胞黏附分子的多唾液酸化形式(PSA-NCAM)、谷氨酸脱羧酶67/65(GAD67/65)和突触素,同时,被神经周网包围的表达小白蛋白的中间神经元数量减少。我们还描述了mPFC中锥体神经元胞体周围抑制性突触点减少的趋势,以及eGFP中间神经元上抑制性突触点密度增加的趋势。最后,我们发现慢性氟西汀治疗会影响mPFC中间神经元的结构,增加其树突棘密度。本研究提供的证据表明,氟西汀可能通过改变神经元或其周围细胞外基质中与可塑性相关的分子,促进成年大脑皮质抑制性神经元的结构变化,这些分子存在于中间神经元中,并且已知对幼年期大脑可塑性关键期的发育至关重要。